tHIS ASEAN 2025 makes its debut next week amid southeast Asia’s medical innovation surge

One of Southeast Asia’s most anticipated medical and healthcare events, The Health Industry Series - ASEAN (tHIS ASEAN 2025) begins next week at the Kuala Lumpur Convention Centre from June 9–11. Organized by Reed Sinopharm Exhibitions in partnership with the Association of Private Hospitals Malaysia (APHM), the event will feature over 200 exhibitors and an expected 5,000+ healthcare professionals, promising a dynamic exchange of innovation, insight, and investment opportunities across the region’s fast-growing health sector.

Unique in the region, tHIS ASEAN serves as a dedicated China-to-ASEAN gateway —bringing curated, credentialed suppliers into direct contact with hospital leaders, procurement teams, distributors, and clinicians seeking reliable and relevant partnerships.

Building on the global reputation of RSE’s flagship exhibitions — CMEF, PHARMCHINA, CRS, CHCC and ICMD — tHIS ASEAN convenes innovators, healthcare professionals, and policymakers to spotlight cutting-edge technologies and to unlock opportunities across medical equipment, pharmaceuticals, rehabilitation, hospital construction, and component manufacturing. The event will be co-located with the APHM International Healthcare Conference & Exhibition.

From China to ASEAN: Advancing Regional Healthcare Together

The exhibition — spanning over 5,000 square meters — is grouped into five key categories, reflecting the current and future engines of growth in ASEAN’s healthcare market:

• Medical equipment: Diagnostic tools, surgical robots, and next-gen imaging technologies
• Pharmaceuticals: Innovative drugs, OTC products, and biotech advancements
• Rehabilitation: Robotic exoskeletons, assistive technologies, and elderly care solutions
• Hospital construction: Smart infrastructure, facility planning, and sustainable design
• Component manufacturing & design: Precision parts, materials, and R&D solutions supporting product development

Amid rising pressure on healthcare budgets, tHIS ASEAN enables buyers to explore cost-effective, regulation-compliant technologies—without sacrificing quality, certification, or scale. The event will feature a large-scale delegation of Chinese manufacturers offering reliable, high-performance solutions built for efficiency and long-term value.

Visitors will have the opportunity to engage directly with suppliers whose products have gained traction in global markets. Notable companies include Sinopharm Group, Mindray, United Imaging, and Gaomai Pharma, among others—providing direct access to next-generation technologies that are both competitive and credible.

Final program unveiled: A platform for progress

Complementing the exhibition is a robust conference program tackling critical themes across innovation, regulation, infrastructure, and cross-border collaboration:

Speakers include regional healthcare policymakers, tech entrepreneurs, and clinical experts who will share actionable insights on the future of the industry, and transfer knowledge such as learnings from hospital construction case studies. These complimentary sessions promise to spark meaningful dialogue and chart the course for ASEAN’s next chapter in healthcare.

Plan your visit

Industry professionals are invited to experience the region’s most comprehensive healthcare showcase — from breakthrough innovations to hands-on demonstrations and expert-led conferences. Whether you’re seeking new technologies, partnerships, or insights, tHIS ASEAN 2025 offers unparalleled opportunities to connect and discover.

For more information and to register for free to attend both exhibition and conferences, visit www.thisasean.com